Many patients with vitiligo, which is an autoimmune disorder characterised by the loss of skin colour in parts of a body, seem to be finding succour in herbal remedies like Lukoskin developed by the Defence and Research Development Organization (DRDO).
Till now, more than one lakh patients suffering from the skin condition, also known as leucoderma, have been treated with Lukoskin with an average success rate of 70 per cent, said Dr Nitika Kohli from AIMIL Healthcare which is manufacturing and marketing the drug.
An ayurveda expert herself, Dr Kohli said, that after DRDO transferred the technology, clinical trials were conducted on the patients and then in 2011 it was launched in the market. “In these ten years, over one lakh patients have been treated with the drug. We found 70 percent success rate,” she said.
An estimated four to five per cent of the Indian population suffers from leucoderma. The condition is characterized by patches of the skin losing their pigment.
The condition is noticeable in people with dark skin.
For better success rate and with an aim to reachout to more patients, the AIMIL is in the process of launching the advanced version of the drug. DRDO is already working in this direction.
Dr Kohli was speaking at a conference “Clinical management of tough skin diseases” held online to mark the ten years of launch of Lukoskin as well as of AIMIL Healthcare.
